LarisaGeskinMDFAAD

Cutaneous Lymphoma, Melanoma

Professor, Director, Cutaneous Oncology Program, Department of Dermatology, Columbia University Irving Medical Center

Overview of Dr. Geskin

Dr. Larisa Geskin is a Professor of Dermatology in Medicine (Hematology-Oncology), she’s dually trained in dermatology and oncology. She’s located in New York, NY and is affiliated with New York-Presbyterian Hospital, Columbia University campus. She received her medical degree from University of Pittsburgh School of Medicine and has been in practice 24 years. She is a world renowned specialist in cutaneous T-cell lymphoma, melanoma and other cutaneous malignancies, including Kaposi sarcoma, Merkel cell carcinoma among others. She’s involved in skin cancer prevention initiatives and research. She’s leading innovative research projects in cutaneous lymphomas and other skin cancers.

Office
161 Fort Washington Avenue
New York, NY 10032
Book by Phone+1(802) 778-0483

Education & Training

UPMC Medical EducationResidency, Dermatology, 1998 - 2001
UPMC Medical EducationInternship, Internal Medicine, 1998 - 1999
University of Pittsburgh School of MedicineClass of 1998

Certifications & Licensure

NY State Medical License 2013 - 2026
PA State Medical License 1999 - 2014
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Top Doctor Castle Connelly, 2014-2024
Lifetime Achievement Award United States Cutaneous Lymphoma Consortium, 2023
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Immunization Against Tumor Cells in Sezary Syndrome Start of enrollment: 2004 Sep 01
Completed
Phase 2
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) Start of enrollment: 2002 Jun 01
Completed
Effect of Denileukin Diftitox on Immune System in CTCL Patients Start of enrollment: 2005 Nov 01
Completed
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug) Start of enrollment: 2010 Nov 01
Withdrawn
Phase 4
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Completed
Phase 3
StrataCTX® as a Steroid Sparing Device Start of enrollment: 2021 Jul 07
Recruiting
Not Applicable
Tissue Repository: CTCL Collection Protocol Start of enrollment: 2016 Jul 01
Recruiting
Roles: Principal Investigator, Contact
Tissue Repository: CTCL Collection Protocol Start of enrollment: 2016 Jul 01
Recruiting
Roles: Principal Investigator, Contact
Photopheresis in Early-stage Mycosis Fungoides Start of enrollment: 2021 May 08
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Maintenance therapy for CTCL: importance for prevention of disease progression.
Emily R Gordon, Megan H Trager, Bradley D Kwinta, Connor J Stonesifer, Kaitlyn J Lee
Leukemia & Lymphoma. 2024-12-01
Decoupling the association of dupilumab with cutaneous T-cell lymphoma.
Zachary J K Neubauer, Patrick M Brunner, Larisa J Geskin, Emma Guttman, Shari R Lipner
Journal of the American Academy of Dermatology. 2024-12-01
A case of testicular diffuse large B-cell lymphoma with late relapse in the skin: the critical role of comparative phenotypic, clonality, and cytogenetic testing.
Oluwaseyi Adeuyan, Madhu M Ouseph, Liming Bao, Michael J Kluk, Jonathan S Goldberg
Leukemia & Lymphoma. 2024-12-01

Abstracts/Posters

Skin Associated Staphylococcus Aureus Contributes to Disease Progression in CTCL
Larisa J Geskin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Management Issues in Cutaneous Lymphoma
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019
Efficacy of mogamulizumab in previously treated patients with less advanced mycosis fungoides: Results from the MAVORIC study.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

CTCL: The Role of Dermatologists in Diagnosing and Caring for PatientsJuly 26th, 2024
Pandemic Caused Treatment Delay for Half of Patients with CTCL, Study FindsDecember 2nd, 2022
What You Need to Know About Sunscreen and Sun Safety: Fact Check with Dr. Larisa GeskinAugust 11th, 2021
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Other Languages

Russian

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PPO
BCBS Georgia Blue Open Access POS
BCBS Illinois PPO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue
Highmark BCBS PPOBlue
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment